Categoría: Heart Disease

Scientists in Egypt demonstrate the ability of bone marrow stem cells to treat chronic cardiac disease that is associated with diabetes.

Advanced Cell Technology and CHA Biotech announce the formation of a new stem cell company through a joint venture agreement.

The adult stem cell company Osiris Therapeutics reaches a production milestone in its agreement with NuVasive.

As an alternative to treating patients with someone else’s stem cells, researchers have improved upon the process of stimulating the body’s own reservoir of endogenous adult stem cells.

The adult stem cell company Osiris Therapeutics accomplishes an historic milestone by completing patient enrollment in the first phase III clinical trial ever to be conducted with adult stem cells in the treatment of Graft versus Host Disease.

Although legitimate adult stem cell therapies are already available, there is also no shortage of bogus stem cell therapies which erroneously claim to offer benefits.

Researchers at Children’s Hospital in Pittsburgh announce that human adult stem cells derived from skeletal muscle have successfully repaired damaged heart tissue more effectively than previously studied therapies.

Doctors announce the successful treatment of pulmonary hypertension with autologous adult stem cells in a clinical trial.

The father of embryonic stem cell science, Dr. James Thomson, merges 3 stem cell companies together into one new commercial endeavor.

Cardiologists in Germany have pioneered a new procedure for the use of adult stem cells derived from umbilical cord blood to grow new heart valves for the repair of congenital heart defects in newborns.